Exhibit 5.1
CONSENT OF INDEPENDENT AUDITOR
We consent to the use in this Amendment No. 3 to the Registration Statement No. 333-229744 on Form F-10 of our report dated March 29, 2018 relating to the consolidated financial statements of Emerald Health Therapeutics, Inc. appearing in the Prospectus, which is part of this Registration Statement.
/s/ Deloitte LLP
Chartered Professional Accountants
Vancouver, Canada
March 14, 2019
